---
title: "Dihydroergotamine - Cluster Headache Syndrome"
sidebar: mydoc_sidebar
permalink: db00320-mesh-d003027-1.html
toc: false 
---


Path ID: `DB00320_MESH_D003027_1`
{% include image.html url="images/db00320-mesh-d003027-1.png" file="db00320-mesh-d003027-1.png" alt="db00320-mesh-d003027-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D004087 | Dihydroergotamine | Drug |
| UniProt:P28221 | 5-hydroxytryptamine receptor 1D | Protein |
| UniProt:P28222 | 5-hydroxytryptamine receptor 1B | Protein |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| GO:1990793 | Substance P secretion, neurotransmission | BiologicalProcess |
| MESH:D010146 | Pain | Disease |
| MESH:D003027 | Cluster headache syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dihydroergotamine | INCREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 1D |
| Dihydroergotamine | INCREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 1B |
| 5-Hydroxytryptamine Receptor 1D | POSITIVELY REGULATES | Vasoconstriction |
| 5-Hydroxytryptamine Receptor 1B | POSITIVELY REGULATES | Vasoconstriction |
| 5-Hydroxytryptamine Receptor 1B | NEGATIVELY REGULATES | Substance P Secretion, Neurotransmission |
| 5-Hydroxytryptamine Receptor 1D | NEGATIVELY REGULATES | Substance P Secretion, Neurotransmission |
| Vasoconstriction | TREATS | Cluster Headache Syndrome |
| Substance P Secretion, Neurotransmission | POSITIVELY CORRELATED WITH | Pain |
| Pain | POSITIVELY CORRELATED WITH | Cluster Headache Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://jamanetwork.com/journals/jamaneurology/fullarticle/782346](https://jamanetwork.com/journals/jamaneurology/fullarticle/782346)
  - [https://go.drugbank.com/drugs/DB00320#BE0000797](https://go.drugbank.com/drugs/DB00320#BE0000797)
